Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-10-21

Clinical Trial Update: Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella

View source ↗

Summary

Clinical trial follow-up and outcomes of pregnancies exposed to Ella (emergency contraception) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ELLA (ULIPRISTAL ACETATE)

Snippet

Sponsor: HRA Pharma | Conditions: Emergency Contraception | Status: COMPLETED | Results posted: 2019-10-21